Skip to content

The effect of oral melatonin on vision improvement in methanol poisoning

Evaluation of the role of oral melatonin in improving vision in methanol poisoning

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200507047344N3
Enrollment
40
Registered
2022-07-05
Start date
2022-08-22
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methadone poisoning. Toxic effect of methanol, accidental (unintentional)

Interventions

Intervention 1: Intervention group: For all patients, methylprednisolone 250 mg every 6 hours to 3 days (equivalent to 1 gram daily for 3 days) is administered as an intravenous infusion (in normal sa

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosis of methanol poisoning No more toxicity through history and negative urine tests for toxicology Having a blurred vision or visual impairment in any form Age range 15 to 60 years Poisoning less than 72 hours before arrival at the hospital Failure to perform cardiopulmonary resuscitation at admission No coma for the patient before entering the study (having a level of consciousness) Consent to participate in the study

Exclusion criteria

Exclusion criteria: People with melatonin contraindications Having sensitive to melatonin Loss of consciousness Having a severe chronic illness (including high blood pressure, liver cirrhosis, congestive heart failure (CHF), chronic respiratory disease, end-stage kidney disease, or a high-risk immune condition (leukemia, lymphoma, or AIDS))

Design outcomes

Primary

MeasureTime frame
Seizures. Timepoint: Upon arrival at the hospital and one week after the intervention. Method of measurement: Observational.;Abnormal CT scan of the brain. Timepoint: Upon arrival at the hospital and one week after the intervention. Method of measurement: Observational.;Visual disorders. Timepoint: 1, 5 and 10 days during the intervention and one week after the intervention. Method of measurement: Ophthalmological examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShafeajafar Zoofaghari

Esfahan University of Medical Sciences

shafeajafar@med.mui.ac.ir+98 31 3268 7610

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026